Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro

Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain an issue in the future making it important to have therapeutics to treat patients. There are few options for treating patients with COVID-19. We show probenecid potently blocks SARS-CoV-2 replication in mammalian...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Jackelyn, Hogan, Robert J., Martin, David E., Blahunka, Kathy, Sancilio, Fred D., Balyan, Rajiv, Lovern, Mark, Still, Richard, Tripp, Ralph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433326/
https://www.ncbi.nlm.nih.gov/pubmed/34508172
http://dx.doi.org/10.1038/s41598-021-97658-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433326/
https://www.ncbi.nlm.nih.gov/pubmed/34508172
http://dx.doi.org/10.1038/s41598-021-97658-w

Ejemplares similares